Majority of the first 50 million doses will go to India, said chief of world's largest drug maker by volume Adar Poonawalla amid delay in approval for the COVID-19 vaccine developed by Oxford and AstraZeneca. Mr Poonawalla was answering a question on whether he is concerned about the delay in approval from UK regulator for Covishield, which had run into controversy last month over its data. "Earlier, we were hearing questions on vaccines being rushed, and now we are hearing questions on why is there no approval yet. You will hear good news from UK soon. You heard the Astra Zeneca CEO say the efficacy would be up to 95 per cent," he said.